TY  - JOUR
AU  - Hendrickx, Sarah
AU  - Ilbeigi, Kayhan
AU  - Thoré, Eli S J
AU  - Bertram, Michael G
AU  - Calvo-Alvarez, Estefanía
AU  - Cintesun, Sener
AU  - Olías-Molero, Ana Isabel
AU  - Corral, María Jesús
AU  - Mateo Barrientos, Marta
AU  - Estaquier, Jérôme
AU  - Pomel, Sébastien
AU  - Alunda Rodríguez, José María
AU  - Gul, Sheraz
AU  - Van Bocxlaer, Katrien
AU  - Frézard, Frédéric
AU  - Tavares, Joana
AU  - Cordeiro Da Silva, Anabela
AU  - Costi, Maria Paola
AU  - Maes, Louis
AU  - Caljon, Guy
PY  - 2026
DO  - 10.1093/jac/dkag110
SN  - 0305-7453
UR  - https://hdl.handle.net/20.500.14352/134931
T2  - Journal of Antimicrobial Chemotherapy (JAC)
AB  - Given the medical importance and challenges related to kinetoplastid diseases, a strategic roadmap is needed for the identification of high-quality leads and drug development candidates. Within the aim to deliver more compelling proof-of-concept...
LA  - eng
M2  - 1
PB  - Oxford University Press
TI  - A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit
TY  - journal article
VL  - 81(4)
ER  -